XML 59 R48.htm IDEA: XBRL DOCUMENT v3.24.2.u1
License Agreement (Details) - vTv Therapeutics - USD ($)
 1 Months Ended 6 Months Ended
Oct. 30, 2023
Dec. 31, 2017
Jun. 30, 2024
Jun. 30, 2023
Research and Development Arrangement, Contract to Perform for Others [Line Items]        
Milestone payments paid   $ 2,000,000    
Development and regulatory milestone payments     $ 2,000,000  
Milestone payments     $ 0 $ 0
Milestone payments payable on achievement of sales thresholds of the licensed product   30,000,000    
Common Stock [Member] | Common Stock Repurchase Agreement        
Research and Development Arrangement, Contract to Perform for Others [Line Items]        
Number of shares repurchased 576,443      
Shares repurchased, aggregate purchase price $ 4,400,000      
Research and development        
Research and Development Arrangement, Contract to Perform for Others [Line Items]        
Upfront license fee payment   $ 3,000,000    
Common stock issued, Shares   576,443    
Milestone payments payable on achievement of development and regulatory milestones   $ 64,500,000